Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Bohmeyer, J
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. [electronic resource] - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Oct 2003 - 785-9 p. digital
Publication Type: Comparative Study; Evaluation Study; Journal Article
1610-0379
10.1046/j.1439-0353.2003.03711.x doi
Adult
Aged
Aminoquinolines--therapeutic use
Anticarcinogenic Agents--administration & dosage
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bexarotene
Combined Modality Therapy
Cyclophosphamide
Disease Progression
Doxorubicin
Female
Humans
Imiquimod
Immunosuppressive Agents--therapeutic use
Interferons--therapeutic use
Lymphoma, T-Cell, Cutaneous--drug therapy
Male
Middle Aged
Neoplasm Staging
PUVA Therapy
Pilot Projects
Prednisone
Remission Induction
Skin--pathology
Skin Neoplasms--drug therapy
Tacrolimus--therapeutic use
Tetrahydronaphthalenes--administration & dosage
Time Factors
Treatment Outcome
Vincristine
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. [electronic resource] - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Oct 2003 - 785-9 p. digital
Publication Type: Comparative Study; Evaluation Study; Journal Article
1610-0379
10.1046/j.1439-0353.2003.03711.x doi
Adult
Aged
Aminoquinolines--therapeutic use
Anticarcinogenic Agents--administration & dosage
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bexarotene
Combined Modality Therapy
Cyclophosphamide
Disease Progression
Doxorubicin
Female
Humans
Imiquimod
Immunosuppressive Agents--therapeutic use
Interferons--therapeutic use
Lymphoma, T-Cell, Cutaneous--drug therapy
Male
Middle Aged
Neoplasm Staging
PUVA Therapy
Pilot Projects
Prednisone
Remission Induction
Skin--pathology
Skin Neoplasms--drug therapy
Tacrolimus--therapeutic use
Tetrahydronaphthalenes--administration & dosage
Time Factors
Treatment Outcome
Vincristine